Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Mar / A Word of Advice
Business & Regulation Profession

A Word of Advice

Looking to set up your own company but lacking business acumen? Help is at hand

By Maryam Mahdi 03/24/2020 1 min read Quick Read (pre 2022)

Share

Start Codon, a life science accelerator which aims to help start up  companies get their feet off the ground, has recently joined Cancer Research UK’s Entrepreneurial Programmes Initiative. The programme aims to promote the development of new business ventures within academia and encourage entrepreneurship in the oncology space. 

Tony Hickson, Chief Business Officer at Cancer Research UK, explained that the newly formed partnership would help address the current translational gap in oncology in the UK and help accelerate more promising ideas into the clinic and to people with cancer.

“Even though many of the professions that the programme is aimed at are in industry already, we want to get them to start thinking more entrepreneurially,” explained Jason Mellad, CEO and Cofounder of Start Codon. “In doing so we expect to see more opportunities for novel technologies to make it to market.” 

One of the biggest challenges for startups, according to Mellad, is that they are unsure of how to get started. “Translating novel technologies into commercial products is a stumbling block for many. Through the Entrepreneurial Programmes Initiatives both Cancer Research and Start Codon will support PhD students, postdocs, and junior group leaders in bridging that gap,” said Mellad.

The programme will help its applicants build a network within the industry. Through the events it plans to host, the applicants will have the chance to meet companies and individuals who have successfully commercialized products, giving them access to relevant and ongoing mentorship.The programme also helps startups get to grips with intellectual property laws, the fundamentals of marketing and how to write foolproof business plans.

“We’re also helping our applicants flesh out ideas that haven’t made it through the programme. They’ll have the opportunity to pitch their ideas and we’ll give them guidance as to how the idea can be launched in the commercial space,” Mellad added.

The partners are now actively looking for companies interested in applying to the programme.

To find out more about what the Entrepreneurial Programmes Initiative has to offer click here.
 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

Peter Marks Resigns from FDA
Standards & Regulation Profession Vaccines Advanced Medicine
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Blood Cancer Success Story: Part 1
Profession Drug Discovery
The Blood Cancer Success Story: Part 1

April 9, 2025

7 min read

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society; because there are some goals you can only accomplish in a not-for-profit environment.

Sitting Down With... Moncef Slaoui
Profession Standards & Regulation Bioprocessing - Upstream & Downstream
Sitting Down With... Moncef Slaoui

March 3, 2025

5 min read

From the GSK boardroom to the White House, and now the board of Abzena, the career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Maintaining Momentum
Profession Advanced Medicine
Maintaining Momentum

February 6, 2025

4 min read

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.